comparemela.com

Latest Breaking News On - Reni benjamin - Page 4 : comparemela.com

StockWatch: Antitrust Fears Dampen Support for $43B Pfizer-Seagen Deal

Pfizer's planned $43 billion purchase of Seagen didn't spark the usual huge stock surge, due to antitrust review concerns.

David risingerJay olsonGregory renzaRaymond jamesAlbert bourlaZhiqiang shuGena wangEtzer daroutReni benjaminDane leoneAndrew berensDavid epsteinBiotech equity researchMerck coMerck kgaEuropean union

StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal

StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Asthika goonewardeneRaymond jamesTeresa buracchioEtzer daroutAstellas pharmaMerck seagenAndrew berensJay olsonJosh schimmerBill dunnGregory renzaReni benjaminMatthew harrisonDane leoneBerenberg zhiqiang shuMichael schmidt

StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal

StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Asthika goonewardeneRaymond jamesTeresa buracchioEtzer daroutAstellas pharmaMerck seagenAndrew berensJay olsonJosh schimmerBill dunnGregory renzaReni benjaminMatthew harrisonDane leoneBerenberg zhiqiang shuMichael schmidt

12 Stocks Insiders are Buying Now - Insider Monkey

Investing in stocks that insiders are buying can sometimes lead to unexpected gains.

United statesWaynep rothbaumRaymond jamesMatthew jacobsonDavidg hannaPershing squareElvira scottoMichael petuskyJean georges vongerichtenJeffreyw ubbenAlexander goldfarbMatt howlettPiper sandlerReni benjaminTaz koujalgiPavel molchanov

JMP Securities Sticks to Their Buy Rating for Seagen (SGEN)

JMP Securities analyst Reni Benjamin reiterated a Buy rating on Seagen (SGEN - Research Report) today and set a price target of $142.00. The compa.

Stifel nicolausReni benjaminIovance biotherapeuticsSpectrum pharmaceuticalsSeagen incJessica fye

vimarsana © 2020. All Rights Reserved.